Ananda's mission is to become a leading UK grower and provider of high quality, consistent, carbon zero medical cannabis for the UK and international markets.
Medical cannabis was legalised in the UK in 2018. There are now almost 20,000 medical cannabis patients in the UK and the number is growing rapidly. Despite this, patient access to medical cannabis is still limited and the majority of medical cannabis products available to UK patients are imported from abroad.
The impact of Ananda as a UK grower and provider will be significant:
- The highest quality cannabis medicines, grown in the UK to the highest UK standards, at low cost.
- The shortest supply chain to ensure patients won’t run out of medicine.
- UK research with UK cannabis medicines to give confidence to prescribers and regulators.
- The team to deliver: a combination of seasoned, successful and driven entrepreneurs together with best-in-class scientists, cultivators and go to market specialists.
At our dedicated cultivation facility in the UK, we are currently working through medical cannabis strain stabilisation research and scaled cultivation trials in readiness for our application to grow for commercial purposes to meet the needs of UK patients and prescribers.